Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of brimonidine tartrate/timolol fixed
combination (Combigan®) compared with brimonidine tartrate (Alphagan®) and timolol in
patients with glaucoma or ocular hypertension who do not respond well to topical beta
blockers.